enVVeno Medical (NVNO) Income from Continuing Operations (2017 - 2026)

enVVeno Medical's Income from Continuing Operations history runs 10 years deep, the most recent figure standing at 4040000.0 for Q1 2026.

• On a quarterly basis, Income from Continuing Operations rose 14.68% year-over-year to 4040000.0 in Q1 2026; TTM through Mar 2026 was 19538000.0, a 15.18% increase from a year earlier, with the FY2025 full-year figure at 20606000.0, up 13.51% from the prior year.
• Income from Continuing Operations declined to 4040000.0 in Q1 2026 per NVNO's latest filing, from 3936000.0 in the prior quarter.
• Across five years, Income from Continuing Operations topped out at 3936000.0 in Q4 2025 and bottomed at 7670000.0 in Q4 2023.
• The 5-year median for Income from Continuing Operations is 6076000.0 (2024), against an average of 5866941.18.
• Across the five-year window, Income from Continuing Operations plunged 146.9% in 2022 and jumped 42.47% in 2025, its largest moves.
• Year by year, Income from Continuing Operations stood at 6714000.0 in 2022, then slipped by 14.24% to 7670000.0 in 2023, then rose by 10.8% to 6842000.0 in 2024, then jumped by 42.47% to 3936000.0 in 2025, then declined by 2.64% to 4040000.0 in 2026.
• Per Business Quant, the three latest NVNO Income from Continuing Operations figures stand at 4040000.0 (Q1 2026), 3936000.0 (Q4 2025), and 4708000.0 (Q3 2025).